
AstraZeneca says updated COVID vaccine report still shows it's highly effective
CBSN
AstraZeneca insisted late Wednesday that its COVID-19 vaccine is strongly effective even after including additional illnesses in its disputed U.S. study, the latest in an extraordinary public rift with American officials.
In a late-night press release, the British drug maker said it had recalculated data from that advanced trial and concluded the vaccine is 76% effective in preventing symptomatic COVID-19, instead of the 79% it had claimed earlier in the week. Just a day earlier, an independent panel that oversees the study had accused AstraZeneca of cherry-picking data to tout the protection offered by its vaccine. The panel, in a harsh letter to the company and to U.S. health leaders, said the company had left out some COVID-19 cases that occurred in the study, a move that could erode trust in the science.
Santa Fe, New Mexico — A representative for the estate of actor Gene Hackman is seeking to block the public release of autopsy and investigative reports, especially photographs and police body-camera video related to the recent deaths of Hackman and wife Betsy Arakawa after their partially mummified bodies were discovered at their New Mexico home in February.

In the past year, over 135 million passengers traveled to the U.S. from other countries. To infectious disease experts, that represents 135 million chances for an outbreak to begin. To identify and stop the next potential pandemic, government disease detectives have been discreetly searching for viral pathogens in wastewater from airplanes. Experts are worried that these efforts may not be enough.